Does psilocybin microdosing improve mood, creativity or focus beyond placebo?

Reliable benefits beyond placebo have not been established by the small controlled studies available here. In a double-blind study of psilocybin mushroom microdosing, participants experienced noticeable subjective effects, but the researchers did not find convincing improvement in well-being, creativity or cognitive function. Another preregistered placebo-controlled study found no effect on anxiety, depression symptoms or emotion processing. These findings are less exciting than testimonials, but they address the question that testimonials cannot: what changes because of the drug rather than expectation or ordinary fluctuation?[1][2]

The studies are small and relatively short, so they do not settle every population, schedule or clinical question. Blinding is also difficult when participants can guess whether they received an active substance. That leaves uncertainty, rather than proof that all reported experiences are imaginary. Research on a supervised, full-dose psilocybin session with psychological support is a different intervention and cannot validate routine microdosing. Long-term safety and durable everyday benefits need their own evidence; feeling a subtle effect is not the same as demonstrating better focus, greater creativity or treatment of a mood disorder.[1][2]